HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS

Clinical trials for HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS explained in plain language.

Never miss a new study

Get alerted when new HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS trials appear

Sign up with your email to follow new studies for HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

Daily shot could transform life for kids with hemophilia

Disease control Ongoing

This study is testing a new medicine called concizumab to see if it can safely prevent bleeding episodes in children under 12 who have hemophilia A or B. Participants will give themselves a daily injection under the skin for 2 to 4 years. The main goal is to see if this daily tre…

Matched conditions: HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS

Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control

Last updated Apr 02, 2026 14:56 UTC

HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS

Get alerted when new HAEMOPHILIA A AND B WITH AND WITHOUT INHIBITORS trials appear

Daily shot could transform life for kids with hemophilia